Barinthus Biotherapeutics (BRNS) Cash from Operations Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 85.14% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -15.72% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | 77.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.41% |
| Dec 31, 2025 | -132.42% |
| Sep 30, 2025 | 41.06% |
| Jun 30, 2025 | -50.83% |
| Mar 31, 2025 | -26.05% |
| Dec 31, 2024 | 166.76% |
| Sep 30, 2024 | -62.61% |
| Jun 30, 2024 | 29.20% |
| Mar 31, 2024 | -272.46% |
| Dec 31, 2023 | -72.82% |
| Sep 30, 2023 | -194.17% |
| Jun 30, 2023 | -102.04% |
| Mar 31, 2023 | 51.76% |
| Dec 31, 2022 | -42.29% |
| Sep 30, 2022 | 688.90% |
| Jun 30, 2022 | 42.61% |
| Mar 31, 2022 | 17.44% |
| Dec 31, 2021 | -62.83% |
| Sep 30, 2021 | -134.38% |
| Jun 30, 2021 | -1,439.37% |